Healthcare -
Biotechnology - NASDAQ - US
$ 327.615
-4 %
$ 7.23 B
Market Cap
-14.96
P/E
MDGL - STOCK-BASED COMPENSATION
Stock-based Compensation MDGL - Madrigal Pharmaceuticals, Inc.
49.7 M
LAST VALUE
36.04%
2 YEAR CAGR
29.82%
5 YEAR CAGR
23.49%
10 YEAR CAGR